Ian N. Moore, CBSTP graduate and investigator lead of the Infectious Diseases Pathogenesis Branch, National Institute of Allergy and Infectious Diseases, is part of the team contributing fundamental life saving research leading to the SARS-CoV-2 vaccine, co-developed by NIH Vaccine Research Center and Moderna approved for Emergency Use by the FDA in the COVID-19 pandemic.